{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:05:00Z","timestamp":1759565100979},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Epithelial ovarian cancer (EOC) is an extremely aggressive and lethal carcinoma. Specific data that identify high-risk groups with uterine involvement are not available. Thus, this study aimed to evaluate a gross number of women with EOC to obtain the frequency of uterine involvement and its risk factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective observational study was conducted on 1900 histologically confirmed EOC women, diagnosed and treated in our tertiary hospital from March 2009 to September 2020. Data including their demographic, medical and pathological findings were collected.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>From 1900 histologically confirmed EOC women, 347 patients were eligible for participations. The mean age of study patients was 51.31\u2009\u00b1\u200911.37\u2009years with the age range of 25 to 87\u2009years. Uterine involvement was detected in 49.6% (173) of the patients either macroscopic (47.4%) or microscopic (52.6%) types.<\/jats:p>\n                <jats:p>Uterine involvement was significantly associated with having AUB (<jats:italic>P<\/jats:italic>-value\u2009=\u20090.002), histological type of ovary tumor (<jats:italic>P<\/jats:italic>-value &lt;\u20090.001), ovarian cancer stage (P-value &lt;\u20090.001), and abnormal CA-125 concentration (P-value\u2009=\u20090.004).<\/jats:p>\n                <jats:p>Compared to the other study patient, the patients with metastatic uterine involvement had significantly higher stage (<jats:italic>p<\/jats:italic>-value&lt;\u20090.001), higher grade of ovary tumor (<jats:italic>p<\/jats:italic>-value\u2009=\u20090.008), serous histological type (p-value&lt;\u20090.001), and a higher level of CA-125 concentration (<jats:italic>p<\/jats:italic>-value&lt;\u20090.001).<\/jats:p>\n                <jats:p>on the other hand, the patients with synchronous uterine cancer were significantly younger (<jats:italic>p<\/jats:italic>-value\u2009=\u20090.013), nulliparous (p-value&lt;\u20090.001), suffered from AUB symptoms (p-value&lt;\u20090.001) and had endometroid histological type (p-value\u2009=\u20090.010) of ovary cancer in comparison to other study patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Considering the high prevalence of uterine involvement in EOC patients, ultrasound evaluation and\/or endometrium biopsy assessment should be done before planning any treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-021-00925-7","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T19:02:32Z","timestamp":1638903752000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Uterine involvement in epithelial ovarian cancer and its risk factors"],"prefix":"10.1186","volume":"14","author":[{"given":"Narges","family":"Zamani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azam Sadat","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setare","family":"Akhavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrzad","family":"Sheikhhasani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somayeh","family":"Nikfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Feizabad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elahe","family":"Rezayof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitra","family":"Modares Gilani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"issue":"1","key":"925_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1525-1438.2007.00975.x","volume":"18","author":"Y-C Chiang","year":"2008","unstructured":"Chiang Y-C, Chen Y-C, Huang C-Y, Hsieh C-Y, Cheng W-F. Synchronous primary cancers of the endometrium and ovary. Int J Gynecol Cancer. 2008;18(1):159\u201364.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"925_CR2","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ygyno.2004.05.006","volume":"94","author":"PT Soliman","year":"2004","unstructured":"Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, Eifel PJ, et al. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecol Oncol. 2004;94(2):456\u201362.","journal-title":"Gynecol Oncol"},{"key":"925_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1006\/gyno.2001.6400","volume":"83","author":"R Zaino","year":"2001","unstructured":"Zaino R, Whitney C, Brady MF, DeGeest K, Burger RA, Buller RE. Simultaneously detected endometrial and ovarian carcinomas. A prospective clinicopathologic study of 74 cases: a Gynaecologic oncology group study. Gynecol Oncol. 2001;83:355\u201362.","journal-title":"Gynecol Oncol"},{"issue":"371","key":"925_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3773","volume":"9","author":"L Kuroki","year":"2020","unstructured":"Kuroki L, Guntupalli SR. Treatment of epithelial ovarian cancer. BMJ. 2020;9(371):m3773.","journal-title":"BMJ."},{"key":"925_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejogrb.2006.06.011","volume":"134","author":"A Bafghi","year":"2007","unstructured":"Bafghi A, Zafrani Y, Pautier P, et al. Endometrial disorders in patients with peritoneal serous papillary carcinoma. Eur J Obstet Gynecol Reprod Biol. 2007;134:101\u20134.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"925_CR6","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"A du Bois","year":"2009","unstructured":"du Bois A, Reuss A, Pujade-Lauraine E, et al. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d\u2019Investigateurs Nationaux pour les etudes des cancers de l\u2019Ovaire (GINECO). Cancer. 2009;115:1234\u201344.","journal-title":"Cancer."},{"key":"925_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/1098-2388(200007\/08)19:1<11::AID-SSU3>3.0.CO;2-3","volume":"19","author":"DE Marsden","year":"2000","unstructured":"Marsden DE, Friedlander M, Hacker NF. Current management of epithelial ovarian carcinoma: a review. Semin Surg Oncol. 2000;19:11\u20139.","journal-title":"Semin Surg Oncol"},{"key":"925_CR8","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ejso.2006.03.036","volume":"32","author":"C Trope","year":"2006","unstructured":"Trope C, Kaern J. Primary surgery for ovarian cancer. Eur J Surg Oncol. 2006;32:844\u201352.","journal-title":"Eur J Surg Oncol"},{"key":"925_CR9","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s11912-007-0067-3","volume":"9","author":"MM Leitao Jr","year":"2007","unstructured":"Leitao MM Jr, Chi DS. Operative management of primary epithelial ovarian cancer. Curr Oncol Rep. 2007;9:478\u201384.","journal-title":"Curr Oncol Rep"},{"key":"925_CR10","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1200\/JCO.2007.11.0932","volume":"25","author":"AN Fader","year":"2007","unstructured":"Fader AN, Rose PG. Role of surgery in ovarian carcinoma. J Clin Oncol. 2007;25:2873\u201383.","journal-title":"J Clin Oncol"},{"key":"925_CR11","doi-asserted-by":"publisher","first-page":"471","DOI":"10.4103\/0019-509X.92259","volume":"48","author":"K Chitrathara","year":"2011","unstructured":"Chitrathara K, Sheikh ZA, Vijaykumar DK, Kuriakose S, Anupama R, Nandeesh M. Is hysterectomy needed in ovarian cancer? Indian J Cancer. 2011;48:471\u20136.","journal-title":"Indian J Cancer"},{"key":"925_CR12","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1097\/00000478-200309000-00009","volume":"27","author":"LM Roth","year":"2003","unstructured":"Roth LM, Emerson RE, Ulbright TM. Ovarian endometrioid tumors of low malignant potential: a clinicopathologic study of 30 cases with comparison to well-differentiated endometrioid adenocarcinoma. Am J Surg Pathol. 2003;27:1253\u20139.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"925_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13048-018-0405-0","volume":"11","author":"SZ Jia","year":"2018","unstructured":"Jia SZ, Zhang JJ, Yang JJ, Xiang Y, Liang Z, Leng JH. Risk of synchronous endometrial disorders in women with endometrioid borderline tumors of the ovary. J Ovarian Res. 2018;11(1):30.","journal-title":"J Ovarian Res"},{"key":"925_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0046-8177(88)80316-2","volume":"19","author":"PM Dvoretsky","year":"1988","unstructured":"Dvoretsky PM, Richards KA, Angel C, Rabinowitz L, Stoler MH, Beecham JB, et al. Distribution of disease at autopsy in 100 women with ovarian cancer. Hum Pathol. 1988;19:57\u201363.","journal-title":"Hum Pathol"},{"issue":"4","key":"925_CR15","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/AOG.0b013e31819c7bdf","volume":"113","author":"MG Williams","year":"2009","unstructured":"Williams MG, Bandera EV, Demissie K, Rodr\u00edguez-Rodr\u00edguez L. Synchronous primary ovarian and endometrial cancers: a population-based assessment of survival. Obstet Gynecol. 2009;113(4):783\u20139.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"925_CR16","doi-asserted-by":"publisher","first-page":"djv442","DOI":"10.1093\/jnci\/djv442","volume":"108","author":"DS Dizon","year":"2016","unstructured":"Dizon DS, Birrer MJ. Making a difference: distinguishing two primaries from metastasis in synchronous tumors of the ovary and uterus. J Natl Cancer Inst. 2016;108(6):djv442.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"925_CR17","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a001693","volume":"3","author":"RC Wu","year":"2017","unstructured":"Wu RC, Veras E, Lin J, Gerry E, Bahadirli-Talbott A, Baras A, et al. Elucidating the pathogenesis of synchronous and metachronous tumors in a woman with endometrioid carcinomas using a whole-exome sequencing approach. Cold Spring Harb Mol Case Stud. 2017;3(6):a001693.","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"3","key":"925_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3802\/jgo.2010.21.3.191","volume":"21","author":"J Menczer","year":"2010","unstructured":"Menczer J, Chetrit A, Sadetzki S. National Israel Ovarian Cancer Group. Uterine metastases in ovarian carcinoma: frequency and survival in women who underwent hysterectomy. J Gynecol Oncol. 2010;21(3):191\u20135.","journal-title":"J Gynecol Oncol"},{"issue":"9","key":"925_CR19","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1097\/IGC.0b013e318227c9ac","volume":"21","author":"MW Bunting","year":"2011","unstructured":"Bunting MW, Jaaback KS, McNally OM. Routine hysterectomy in the surgical management of ovarian cancer: a retrospective case series, physician opinion survey, and review of the literature. Int J Gynecol Cancer. 2011;21(9):1579\u201384.","journal-title":"Int J Gynecol Cancer"},{"key":"925_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1006\/gyno.2001.6400","volume":"83","author":"R Zaino","year":"2001","unstructured":"Zaino R, Whitney C, Brady MF, DeGeest K, Burger RA, Buller RE. Simultaneously detected endometrial and ovarian carcinomas\u2013a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study. Gynecol Oncol. 2001;83:355\u201362.","journal-title":"Gynecol Oncol"},{"key":"925_CR21","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/modpathol.3800752","volume":"20","author":"CC van Niekerk","year":"2007","unstructured":"van Niekerk CC, Vooijs GP, Bulten J, van Dijck JA, Verbeek AL. Increased risk of concurrent primary malignancies in patients diagnosed with a primary malignant epithelial ovarian tumor. Mod Pathol. 2007;20:384\u20138.","journal-title":"Mod Pathol"},{"key":"925_CR22","volume-title":"Tumors of the ovary, Maldeveloped gonads, fallopian tube, and broad ligament","author":"RE Scully","year":"1998","unstructured":"Scully RE, Young RH, Clement PB. Tumors of the ovary, Maldeveloped gonads, fallopian tube, and broad ligament. Washington, D.C.: Armed Forces Institute of Pathology; 1998."},{"issue":"8","key":"925_CR23","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1097\/IGC.0b013e3182679119","volume":"22","author":"FM Broeders","year":"2012","unstructured":"Broeders FM, van der Wurff AA, Pijnenborg JM, Vos MC. Preoperative identification of synchronous ovarian and endometrial cancers: the importance of appropriate workup. Int J Gynecol Cancer. 2012;22(8):1325\u201331.","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"925_CR24","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00404-011-2046-z","volume":"285","author":"A Rodolakis","year":"2012","unstructured":"Rodolakis A, Thomakos N, Akrivos N, Sotiropoulou M, Ioannidis I, Haidopoulos D, et al. Clinicopathologic insight of simultaneously detected primary endometrial and ovarian carcinomas. Arch Gynecol Obstet. 2012;285(3):817\u201321.","journal-title":"Arch Gynecol Obstet"},{"issue":"11","key":"925_CR25","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1111\/jog.12826","volume":"41","author":"H Sozen","year":"2015","unstructured":"Sozen H, Vatansever D, Iyibozkurt AC, Topuz S, Ozsurmeli M, Salihoglu Y, et al. Clinicopathologic and survival analyses of synchronous primary endometrial and epithelial ovarian cancers. J Obstet Gynaecol Res. 2015;41(11):1813\u20139.","journal-title":"J Obstet Gynaecol Res"},{"issue":"5","key":"925_CR26","doi-asserted-by":"publisher","first-page":"508","DOI":"10.5301\/tj.5000378","volume":"102","author":"U Solmaz","year":"2016","unstructured":"Solmaz U, Karatasli V, Mat E, Dereli L, Hasdemir PS, Ekin A, et al. Synchronous primary endometrial and ovarian cancers: a multicenter review of 63 cases. Tumori. 2016;102(5):508\u201313.","journal-title":"Tumori."},{"issue":"4","key":"925_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4999\/uhod.151002","volume":"30","author":"MA Narin","year":"2015","unstructured":"Narin MA, Karalok A, Basaran D, Ureyen I, Turkmen O, Turan T, et al. Coexisting primary cancers of endometrium and ovary: experience of single institution. Int J Hematol Oncol. 2015;30(4):172\u20137.","journal-title":"Int J Hematol Oncol"},{"key":"925_CR28","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/465162","volume":"2010","author":"CC van Niekerk","year":"2010","unstructured":"van Niekerk CC, Bulten J, Vooijs GP, Verbeek AL. The association between primary Endometrioid carcinoma of the ovary and synchronous malignancy of the endometrium. Obstet Gynecol Int. 2010;2010:465162.","journal-title":"Obstet Gynecol Int"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-021-00925-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-021-00925-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-021-00925-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T19:02:35Z","timestamp":1638903755000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-021-00925-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["925"],"URL":"https:\/\/doi.org\/10.1186\/s13048-021-00925-7","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"2 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained from the Ethical Committee of Tehran University of Medical Sciences (IR.TUMS.IKHC.REC.1399.050). This study was conducted in compliance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}